Followers | 130 |
Posts | 18112 |
Boards Moderated | 0 |
Alias Born | 01/16/2007 |
Sunday, December 21, 2014 2:20:34 PM
For details on how each calculation was performed, simply link back to previous post, at top left corner of this post. All the calculations are there.
HHSE 10-Q Financials Period Ended September 30, 2014:
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=129673
HHSE Third Quarter 10-Q HIGHLIGHTS
- 19 out of 19 Consecutive Quarters of Revenues & Profits
- Theatrical Servicing Fees = $80,000
- VODwiz Income* = $ 23,245
- Total Revenues = $407,605
- Net Income = $215,273
- Retained Earnings, End of Period = $5,211,633
- Accounts Receivable** $ 3,574,189
* VODwiz income during Q3 was derived entirely from mastering fees charged by Company to supplier partners as part of the on-boarding processes for the forthcoming consumer launch of the portal.
** Accounts Receivable includes the gross contract values for fully-accepted, credit-worthy international presale agreements ($2,500,000), for which the net amount payable to producers / licensors is expensed on the liability detail. Company has retained previously recognized international presales and coproduction contracts, but has intentionally withheld recognition of new contracts and presales obtained during or after the Cannes Festival and Market, so that these revenues may be recognized at a later date, likely upon delivery of the subject films. Company has elected to defer realization of additional International Presales and Co-Production agreements until deliver of each film production is acknowledged.
All HHSE SEC EDGAR Filings:
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001069680&owner=include&count=40
http://www.nasdaq.com/symbol/hhse/sec-filings
All HHSE Financials & Filings at OTC Markets:
http://www.otcmarkets.com/stock/HHSE/filings
HHSE
Recent HHSE News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 07:17:02 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM